Clinical

Vertex scores FDA nod for kids’ cystic fibrosis drug Trikafta

Trikafta was approved by FDA for the treatment of Cystic Fibrosis in patients aged 6 to 11 years, after receiving approval to be used in patients of ages 12 and up

Bristol Myers Squibb’s multiple sclerosis drug Zeposia gets FDA approval for ulcerative colitis

The drug Ozanimod (zeposia) has been approved by United States FDA (Food and Drug Administration) for individuals having mild to Severe Ulcerative Colitis.

Amgen’s KRAS drug gets early FDA approval for lung cancer with specific mutation

On Friday, the United States FDA (Food and Drug Administration) has authorized a medication of Amgen Biopharmaceutical in patients with NSCLC

Myovant Sciences and Pfizer get the FDA nod on MYFEMBREE® to treat heavy menstrual bleeding with once a day treatment

The United States FDA ( Food and Drug Administration) has authorized MYFEMBREE ( relugolix 40mg, estradiol 1mg, norethindrone acetate 0.5mg)

Third antibody treatment for early COVID infection approved by the FDA

The United States FDA ( Food and Drug Administration) has approved the monoclonal antibody therapy treatment of Vir Biotechnology and GSK ( GlaxoSmithKline) on Wednesday

Japan’s MHLW approves AstraZeneca and Moderna Covid-19 vaccines

Japan’s Ministry of Health, Labour, and the Welfare department (MHLW) has approved Moderna’s COVID-19 mRNA vaccine and Vaxzevria

Janssen files for Covid19 vaccine approval in Japan

Janssen pharmaceuticals K.K., a department of Johnson& Johnson pharmaceuticals, has announced on Monday that it has applied to the Health Ministry of Japan to approve its Covid-19 vaccine.

Cerecor’s Covid-19 antibody treatment will get fast-track treatment from FDA

Cerecor, a complete human monoclonal antibody CERC-002, has received timely approval by the U.S. Food and Drug Administration (FDA)

Latest news

Sionna Therapeutics Targets $156 Million in IPO to Advance Cystic Fibrosis Research

Sionna Therapeutics, a biotechnology firm headquartered in Waltham, Massachusetts, is preparing to raise up to $156 million through an...

AdvanCell Bags $112M in Series C Funding For Alpha Radiopharma Trial

AdvanCell has raised $112 million in a Series C fundraising round supported by Sanofi Ventures. The Australian radiopharmaceutical firm...

Atalanta Therapeutics Secures $97 Million to Advance siRNA Therapies for Neurological Disorders

Atalanta Therapeutics has raised $97 million in a successful Series B financing round, which will support the initiation of...

Must read

Surrounded by controversy, FDA approves Biogen’s Alzheimer’s drug Aduhelm

In the middle of the debate about the Alzheimer’s drug approval, the United States FDA has authorized Aduhelm

You might also likeRELATED
Recommended to you

Surrozen Abandons IBD Treatment SZN-1326

Surrozen finds itself at a crossroads in...

J&J and Protagonist Therapeutics’ Oral Psoriasis Drug Shows Positive Results in Phase 3 Trial

Hailed as the first oral peptide designed to selectively...

Novo Nordisk expands facility to increase production

Novo Nordisk will invest $744 million to...